Modeling Risk Group 4 virus infection and antiviral treatment in microfluidic lung organ-on-chips in maximum containment laboratories
Sushma M. Bhosle, Julie P. Tran, Shuǐqìng Yú, Jillian Geiger, Arpita Das, Scott M. Anthony, Bapi Pahar, Rebecca Bernbaum-Cutler, Deja F. P. Rivera, Ian Crozier, Jiro Wada, Anya Crane, Gustavo F. Palacios, Nicole Kleinstreuer, Jens H. Kuhn, Gabriella Worwa
The paper demonstrates the use of microfluidic lung organ-on-chips to model NiV infection and evaluate antiviral treatments in a biosafety level 4 lab.
bioRxiv · Aug 25, 2026 · PreprintMicrobiology